- Published at
- by manilatimes.net
positive
positive
News for PCI Biotech Holding ASA (0JGL.L)
- Published at
- by gurufocus.com
neutralneutralQ2 2022 PCI Biotech Holding ASA Earnings Call Transcript
Aug 31, 2022 / 06:30AM GMTHans Peter Bohn - PCI Biotech Holding ASA - Independent Chairman Second quarter presentation. I'm Hans Peter Bøhn, I'm the Chairman- Published at
- by gurufocus.com
positivepositiveQ1 2022 PCI Biotech Holding ASA Earnings Call Transcript
May 11, 2022 / 06:30AM GMTPer Walday - PCI Biotech Holding ASA - CEO Good morning, and welcome to PCI Biotech First Quarter 2022 Presentation. My name is Per Wa- Published at
- by gurufocus.com
positivepositivePCI Biotech Holding ASA Update on RELEASE Trial Call Transcript
Jan 25, 2022 / 01:00PM GMTHans Peter Bohn - PCI Biotech Holding ASA - Independent Chairman Good afternoon, and welcome to this webcast from PCI Biotech. To thos- Published at
- by gurufocus.com
positivepositiveQ4 2021 PCI Biotech Holding ASA Earnings Presentation Transcript
Feb 18, 2022 / 07:30AM GMTPresentationFeb 18, 2022 / 07:30AM GMT =====================Corporate Participants===================== * Per Walday PCI Biote- Published at
- by gurufocus.com
positivepositiveQ3 2021 PCI Biotech Holding ASA Earnings Call Transcript
Nov 17, 2021 / 07:30AM GMTPer Walday - PCI Biotech Holding ASA - CEO Welcome to PCI Biotech Third Quarter 2021 Presentation. My name is Per Walday, and I'm the- Published at
- by gurufocus.com
positivepositiveQ3 2020 PCI Biotech Holding ASA Earnings Call Transcript
Nov 11, 2020 / 07:30AM GMTPer Walday - PCI Biotech Holding ASA - CEO Good morning, and welcome to PCI Biotech's Third Quarter Presentation 2020. My name is Per- Published at
- by gurufocus.com
positivepositiveQ2 2020 PCI Biotech Holding ASA Earnings Call Transcript
Aug 26, 2020 / 06:30AM GMTPer Walday - PCI Biotech Holding ASA - CEO Good morning, and welcome to PCI Biotech Second Quarter First Half 2020 Presentation Webcas- Published at
- by gurufocus.com
neutralneutralQ1 2020 PCI Biotech Holding ASA Earnings Call Transcript
May 06, 2020 / 06:30AM GMTOperator Good morning, and welcome to this first quarter 2020 presentation for PCI Biotech. My name is Per Walday, and I'm the CEO of- Published at
- by gurufocus.com
positivepositiveHalf Year 2019 PCI Biotech Holding ASA Earnings Call Transcript
Aug 28, 2019 / 06:30AM GMTPer Walday - PCI Biotech Holding ASA - CEO Good morning, everyone, and welcome to our PCI Biotech's Second Quarter and First Half 2019- Published at
- by marketscreener.com
mixedmixedPCI Biotech initiates field testing of its proprietary technology for gene therapy manufacturing
Oslo, Norway, 13 October 2023 – PCI Biotech today announced a research collaboration agreement with the aim to address critical pain points in the manufacturing of gene therapies. The partners...- Published at
- by marketscreener.com
positivepositivePCI Biotech interim Q1 2023 results
Oslo , 12 May 2023 – PCI Biotech , today announces its interim Q1 2023 results. Please find enclosed the report and presentation. Highlights reviewfimaNAc – bioprocessingThe... | May 12, 2023- Published at
- by marketscreener.com
positivepositivePCI Biotech interim Q4 2022 results
Oslo , 17 February 2023 – PCI Biotech , today announces its interim Q4 2022 results. Please find enclosed the report and presentation. Highlights fimaNAc – dermatology and... | February 17, 2023- Published at
- by marketscreener.com
positivepositivePCI Biotech: Employee share option scheme
Oslo, 25 November 2022 - PCI Biotech , today announce that the Board of Directors has granted share options to key employees. In accordance with the... | November 25, 2022- Published at
- by marketscreener.com
positivepositivePCI Biotech interim Q3 2022 report
Oslo , 23 November 2022 – PCI Biotech , today announces its interim Q3 2022 results. Please find enclosed the report and presentation. Highlights Corporate*Efforts to finance a Ph II clinical... | November 23, 2022- Published at
- by marketscreener.com
mixedmixedPCI Biotech: Invitation to Q3 2022 results presentation
Oslo, Norway, 17 November 2022 - PCI Biotech invites to an online presentation of the company's Q3 2022 interim report on Wednesday 23 November 2022, 08:30am – 09:30am CET . The... | November 17, 2022- Published at
- by marketscreener.com
mixedmixedPCI Biotech fourth quarter and preliminary full year 2021 results
Oslo , 18 February 2022 – PCI Biotech , a cancer focused biopharmaceutical company, today announces its interim Q4 and preliminary full-year 2021 results. Please find enclosed the report... | February 18, 2022